Dosage ; Rheumatoid arthritis and osteoarthritis: 7.5-15mg/day.
Maximum recommended daily dose is 15mg/day.
Rectal administration: One suppository containing 15mg once daily.
The total dosage both orally and rectally should not exceed 15mg
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Bettam | Unison Laboratories | Omaera Pharmaceuticals Ltd | 7.5mg | 30 | Tablet | per tablet | KES 780 |
| Melcam | Square Pharmaceuticals Ltd | ACE Pharmaceuticals Ltd | 7.5mg | 100 | Tablet | per tablet | KES 450.00 |
| Melcam | Square Pharmaceuticals Ltd | ACE Pharmaceuticals Ltd | 15mg | 50 | Tablet | per tablet | KES 450.00 |
| Meloxicam | Novell Pharmaceutical Laboratories | Kulal International Ltd. | 7.5mg | 20 | Tablet | per tablet | KES 135 |
| Mexic | Prism Life Sciences | Galaxy Pharmaceuticals Ltd | 7.5mg | 30 | Tablet | per tablet | KES 160.00 |
| Mexic | Prism Life Sciences | Galaxy Pharmaceuticals Ltd | 15mg | 30 | Tablet | per tablet | KES 360.00 |
| Mobic | Boehringer Ingelheim International | Pharma Specialities Ltd. | 7.5mg | 30 | Tablet | per tablet | KES 1,403 |
| Mobic | Boehringer Ingelheim International | Pharma Specialities Ltd. | 15mg | 10 | Tablet | per tablet | KES 704 |
| Mobic | Boehringer Ingelheim International | Pharma Specialities Ltd. | 15mg | 30 | Tablet | per tablet | KES 2,214 |
| Mobic | Boehringer Ingelheim International | Pharma Specialities Ltd. | 15mg | 5 | Injection | per vial | KES 522 |
| Sucentis | Cipla Ltd. | Lords Healthcare Ltd. | 15mg | 10 | Tablet | per tablet | KES 190 |
| Uxim | Universal Pharmaceuticals Ltd. | Europa Healthcare Ltd. | 7.5mg | 20 | Tablet | per tablet | KES 119.00 |
| Uxim | Universal Pharmaceuticals Ltd. | Europa Healthcare Ltd. | 15mg | 20 | Tablet | per tablet | KES 168.00 |
| Anticox II | Adwia | Salama Pharmaceuticals Ltd. | 7.5mg | 10 | Tablet | per tablet | KES 195.00 |
| Anticox II | Adwia | Salama Pharmaceuticals Ltd. | 15mg | 20 | Tablet | per tablet | KES 420.00 |
| Anticox II | Adwia | Salama Pharmaceuticals Ltd. | 15mg | 6 | Injection | per vial | KES 420.00 |
| Melonac | Syner-Medica (K) Ltd | Syner-Medica (K) Ltd | 7.5mg | 30 | Tablet | per tablet | KES 300.00 |
| Melonac | Syner-Medica (K) Ltd | Syner-Medica (K) Ltd | 15mg | 30 | Tablet | per tablet | KES 520.00 |
| Mel-Od | Zydus Cadila Healthcare | Harley's Limited | 7.5mg | 30 | Tablet | per tablet | KES 100.00 |
| Mel-Od | Zydus Cadila Healthcare | Harley's Limited | 15mg | 30 | Tablet | per tablet | KES 140.00 |
| Muvera | Sun Pharmaceuticals Ltd | Sunpar Pharmaceuticals Ltd. | 7.5mg | 100 | Tablet | per tablet | KES 1,900.00 |
| Muvera | Sun Pharmaceuticals Ltd | Sunpar Pharmaceuticals Ltd. | 15mg | 100 | Tablet | per tablet | KES 3,250.00 |
| Meloxicam more info | |
|---|---|
| Mode Of Action | Selective COX-2 inhibitor. Inhibition of COX-2 provides the therapeutic effects of NSAIDs while that of COX-1 is responsible for gastric and renal side effects. |
| Drug Indication | Osteoarthritis, rheumatoid arthritis. |
| Contra-Indications | Known hypersensitivity to NSAIDS, pregnancy or breastfeeding, those below 15 years, active PUD, severe renal and hepatic insufficiency. |
| Side Effects | Dyspepsia, nausea, vomiting, diarrhoea, anaemia, pruritus, skin rash, light-headedness, headache, vertigo, drowsiness and oedema. |
| Dosage | Rheumatoid arthritis and osteoarthritis: 7.5-15mg/day. Maximum recommended daily dose is 15mg/day. Rectal administration: One suppository containing 15mg once daily. The total dosage both orally and rectally should not exceed 15mg. |
| Pregnancy Category | Category C |
| Pregnancy Category Description | Drugs which, owing to their pharmacological effects, or may be suspected of causing detrimental effects on human foetus or neonates without causing malfunctions. These effects may be reversible |
| Drug Category | DRUGS ACTING ON CNS |
| Drug Sub-Category | Analgesics, Antipyretics & NSAIDS |